Celldex Therapeutics Net Profit Margin Growth & History (CLDX)
Celldex Therapeutics's net profit margin was −16,748.03% for fiscal 2025.
View full Celldex Therapeutics company overviewCelldex Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −16,748.03% | −14499.27 pp |
| 2024 | 2024-12-31 | −2,248.76% | −194.00 pp |
| 2023 | 2023-12-31 | −2,054.76% | +2710.83 pp |
| 2022 | 2022-12-31 | −4,765.59% | — |
Celldex Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −334,104.55% | −326351.12 pp |
| Q1 2026 | 2026-03-31 | −524,566.67% | −516826.24 pp |
| Q4 2025 | 2025-12-31 | −67,764.17% | −63756.34 pp |
| Q2 2025 | 2025-06-30 | −7,753.42% | −6318.60 pp |
| Q1 2025 | 2025-03-31 | −7,740.43% | +13290.34 pp |
| Q4 2024 | 2024-12-31 | −4,007.83% | — |
| Q3 2024 | 2024-09-30 | −1,319.99% | — |
| Q2 2024 | 2024-06-30 | −1,434.83% | — |
| Q1 2024 | 2024-03-31 | −21,030.77% | — |
| Q2 2011 | 2011-06-30 | −524.39% | −201.61 pp |
| Q2 2010 | 2010-06-30 | −322.77% | — |
Celldex Therapeutics net profit margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Celldex Therapeutics's net profit margin decreased from −4,765.59% to −16,748.03%, a change of −11982.43 percentage points. The latest reported quarter, Q2 2026, shows −334,104.55%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Celldex Therapeutics source filings ↗